Adma Biologics reported $16.94M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Adma Biologics ADMA:US $ 16.94M 33.64M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Minerva Neurosciences NERV:US $ 6.97M 1.02M
Novavax NVAX:US $ 668.88M 174.21M
Omeros OMER:US $ 37.44M 2.39M
Takeda 4502:JP 821.95B 52.96B